Gene · 5166
Papers3,136
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,136
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic Determinants of Cardiomyocyte Proliferation. | Stem Cells | 2022 | 35263763 | PubTator, text mining | PubMed |
| Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment. | Semin Cancer Biol | 2022 | 35259492 | PubTator, text mining | PubMed |
| Fenofibrate reduces cisplatin-induced apoptosis by inhibiting the p53/Puma/Caspase-9 pathway and the MAPK/Caspase-8 pathway rather than by promoting autophagy in murine renal proximal tubular cells. | Biochem Biophys Rep | 2022 | 35252595 | PubTator, text mining | PubMed |
| Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4. | Oxid Med Cell Longev | 2022 | 35251469 | PubTator, text mining | PubMed |
| Exploring compounds to be used as cosmetic agents that activate peroxisome proliferator-activated receptor alpha. | Int J Cosmet Sci | 2022 | 35244215 | PubTator, text mining | PubMed |
| Downregulation of ALDH6A1 is a New Marker of Muscle Insulin Resistance in Type 2 Diabetes Mellitus. | Int J Gen Med | 2022 | 35241929 | PubTator, text mining | PubMed |
| The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia. | Nat Commun | 2022 | 35232995 | PubTator, text mining | PubMed |
| Searching for genetic modulators of the phenotypic heterogeneity in Brugada syndrome. | PLoS One | 2022 | 35231055 | PubTator, text mining | PubMed |
| Intact mitochondrial substrate efflux is essential for prevention of tubular injury in a sex-dependent manner. | JCI Insight | 2022 | 35230975 | PubTator, text mining | PubMed |
| miR-32 promotes MYC-driven prostate cancer. | Oncogenesis | 2022 | 35228520 | PubTator, text mining | PubMed |
| Diagnostic, Therapeutic, and Prognostic Value of the m6A Writer Complex in Hepatocellular Carcinoma. | Front Cell Dev Biol | 2022 | 35223847 | PubTator, text mining | PubMed |
| Single-cell Transcriptomic Architecture Unraveling the Complexity of Tumor Heterogeneity in Distal Cholangiocarcinoma. | Cell Mol Gastroenterol Hepatol | 2022 | 35219893 | PubTator, text mining | PubMed |
| Metformin: Expanding the Scope of Application-Starting Earlier than Yesterday, Canceling Later. | Int J Mol Sci | 2022 | 35216477 | PubTator, text mining | PubMed |
| 29 m6A-RNA Methylation (Epitranscriptomic) Regulators Are Regulated in 41 Diseases including Atherosclerosis and Tumors Potentially via ROS Regulation - 102 Transcriptomic Dataset Analyses. | J Immunol Res | 2022 | 35211628 | PubTator, text mining | PubMed |
| Over-Reduced State of Mitochondria as a Trigger of "β-Oxidation Shuttle" in Cancer Cells. | Cancers (Basel) | 2022 | 35205619 | PubTator, text mining | PubMed |
| Quantifying the Patterns of Metabolic Plasticity and Heterogeneity along the Epithelial-Hybrid-Mesenchymal Spectrum in Cancer. | Biomolecules | 2022 | 35204797 | PubTator, text mining | PubMed |
| Functional and Genetic Characterization of Porcine Beige Adipocytes. | Cells | 2022 | 35203402 | PubTator, text mining | PubMed |
| Functional Interactions Between lncRNAs/circRNAs and miRNAs: Insights Into Rheumatoid Arthritis. | Front Immunol | 2022 | 35197980 | PubTator, text mining | PubMed |
| Interleukin-6 potentiates endurance training adaptation and improves functional capacity in old mice. | J Cachexia Sarcopenia Muscle | 2022 | 35191221 | PubTator, text mining | PubMed |
| Interplay Between m6A RNA Methylation and Regulation of Metabolism in Cancer. | Front Cell Dev Biol | 2022 | 35186927 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5166/papers?page=49